All the potential medicines under development target Gram-negative bacteria, among the most dangerous types of superbugs because they are increasingly resistant to most available antibiotics. They include CRE, or carbapenem-resistant Enterobacteriaceae (shown), which U.S. health officials have dubbed “nightmare bacteria.”